Published in Surgery Litigation and Law Weekly, December 8th, 2006
HemCon's chitosan platform technology is most being used as the basis for their proprietary hemorrhage control bandage. This bandage, which the company states is in wide use by the U.S. Army, is capable of controlling severe arterial bleeding. HemCon's technology is also being applied towards: oral surgery dental dressings, advanced wound care, and over-the-counter applications.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.